UF
CRL icon

Univest Financial’s Charles River Laboratories CRL Stock Holding History

Univest Financial’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,652
Closed -$402K – 264
2025
Q2 		$402K Sell
2,652
-31,595
-92% -$4.21M 0.02% 205
2025
Q1 		$5.15M Sell
34,247
-6,325
-16% -$1.06M 0.34% 59
2024
Q4 		$7.49M Sell
40,572
-5,944
-13% -$1.14M 0.47% 51
2024
Q3 		$9.16M Buy
46,516
+30,264
+186% +$6.29M 0.6% 42
2024
Q2 		$3.36M Sell
16,252
-386
-2% -$87.5K 0.93% 40
2024
Q1 		$4.51M Sell
16,638
-475
-3% -$113K 1.27% 23
2023
Q4 		$4.05M Sell
17,113
-63
-0.4% -$12.4K 1.2% 30
2023
Q3 		$3.37M Sell
17,176
-265
-2% -$54.4K 1.12% 34
2023
Q2 		$3.67M Buy
+17,441
New +$3.47M 1.11% 39

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Univest Financial's CRL Position: Q3 2025 in Review

Univest Financial sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 2,652 shares — an estimated $402K sold.

Univest Financial first reported a position in CRL in Q2 2023 and held it in 9 quarters. The position peaked at $9.16M in Q3 2024. 554 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Univest Financial reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
  • Univest Financial sold 2,652 Charles River Laboratories shares in Q3 2025, an estimated $402K.
  • Univest Financial first reported a position in Charles River Laboratories in Q2 2023 and held it in 9 quarters.
  • Univest Financial's Charles River Laboratories position peaked at $9.16M in Q3 2024.
  • 554 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Univest Financial's 13F filing for Q3 2025, filed 30 Oct 2025.